Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-09-08
1999-08-10
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514885, 514860, 514813, 424 851, 424 852, A61K 3800
Patent
active
059359293
ABSTRACT:
A method for the treatment and prevention of immune disorders and fibrosis associated disorders is disclosed. The method involves administering interleukin-9 in an effective amount to the subject. Among the conditions treatable are thyroiditis, autoimmune diabetes and silicosis.
REFERENCES:
patent: 5132109 (1992-07-01), Dugas et al.
patent: 5414071 (1995-05-01), Yang et al.
patent: 5830454 (1998-11-01), Renauld
Immunology, ed. Roitt et al., pp. 13.19 and 23.1-23.11, 1985.
Biomed & Pharmacother, SM Hsu, 48, 433-444, 1944.
American Journal of Pathology, Rakesh K. Kumar, vol. 135, No. 4, 1989.
Thorax, Naohito Suzuki et al., vol. 51, 1036-1042, 1996.
Many, et al., "Two-step developoment of Hashimoto-like thyroiditis in genetically autoimmune prone non-obese diabetic mice: effects of iodine-induced cell necrosis", J. Endocrinol 147: 311-320 (1995).
Remick et al., ed., "Cytokines in Health and Disease", 2nd ed., Marcel Dekker, Inc. (New York, 1997), pp. 133-141, 519-529.
Kurzrock et al., "Cytokines: Interleukins and Their Receptors", Kluwer Academic Publishers, Boston, 1995, pp. 143-157, 187-303, discuss IL-4 (pp. 143-157, and IL-9 (287-303).
Brennan et al., ed., "Cytokines in Autoimmunity", Chapman & Hall, Austin, 1996, pp. 1-5, 9-20, 25-31, 49-53, 65-75, 77-81, 101-119, 121, 137-139, and 153-157.
Huaux Francois
Lison Dominique
Many Mary-Christine
Renauld Jean-Christophe
Ludwig Institute for Cancer Research
Moezie F. T.
LandOfFree
Methods for treating interstitial lung disease by using interleu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating interstitial lung disease by using interleu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating interstitial lung disease by using interleu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1120131